Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer. It provides cancer patients with therapies targeting mutated proteins called neo-antigens, which are present on cancer cells as a consequence of DNA mutations.